Sort
10,766 grants matching “checkpoint inhibitor”
Enhancing triple negative breast cancer response to immune checkpoint inhibitor therapy via targeted therapies
$7,461Kennady Bullock · Vanderbilt University · F31 · FY2024 · CA
Cyclin-dependent kinase control of cell-division and transcription cycles
$7,332Robert P Fisher · Icahn School Of Medicine At Mount Sinai · R35 · FY2021 · GM
Checkpoints of TNF Gene Regulation
$7,290Anne Goldfeld · Boston Children'S Hospital · R01 · FY2014 · GM
Clinical Investigations and Precision Therapeutics
$7,153Janice M. Mehnert · Rbhs -Cancer Institute Of New Jersey · P30 · FY2019 · CA
SPINDLE CHECKPOINT SIGNALING
$7,064Kevin S Hardwick · University Of Washington · P41 · FY2010 · RR
Mechanism of Immune Dysfunction and Morbid Outcomes in Response to Shock/Sepsis
$7,057Alfred Ayala · Rhode Island Hospital · R35 · FY2024 · GM
Durvalumab in Combination with Olaparib in Non-Small Cell Lung Cancer
$7,024Arun Rajan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
2020 DNA Damage, Mutation and Cancer GRC/GRS
$7,000Hannah L Klein · Gordon Research Conferences · R13 · FY2020 · CA
Cancer Immunology Program - 03
$6,864Drew M. Pardoll · Johns Hopkins University · P30 · FY2018 · CA
Breast and Ovarian Cancer Program - 08
$6,863Vered Stearns · Johns Hopkins University · P30 · FY2018 · CA
Live cell reporters of genetic changes in stiff vs soft surroundings - Causes & Consequences
$6,689Dennis E. Discher · University Of Pennsylvania · U01 · FY2024 · CA
Applying deep learning to predict T cell receptor binding specificity of neoantigens and response to checkpoint inhibitors
$6,465Tao Wang · Ut Southwestern Medical Center · R01 · FY2023 · CA
Cancer Cell Biology and Signaling Research Program
$6,313Vivek M Rangnekar · University Of Kentucky · P30 · FY2018 · CA
Program 30: Neuro-Oncology
$6,168Charles Stiles · Dana-Farber Cancer Inst · P30 · FY2019 · CA
Program 4: Leukemia
$6,168Benjamin Levine Ebert · Dana-Farber Cancer Inst · P30 · FY2019 · CA
Innate and Non-Classical Immune Cells in Cancer Immunotherapy
$6,000Thale Cross Jarvis · Keystone Symposia · R13 · FY2019 · CA
Role of melanoma-PD-1 in cancer progression
$5,903Tobias Schatton · Brigham And Women'S Hospital · R01 · FY2019 · CA
Program 4: Leukemia
$5,849Benjamin Levine Ebert · Dana-Farber Cancer Inst · P30 · FY2018 · CA
Program 30: Neuro-Oncology
$5,848Charles Stiles · Dana-Farber Cancer Inst · P30 · FY2018 · CA
Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer
$5,840Alice Berger · Fred Hutchinson Cancer Center · R37 · FY2024 · CA
Signaling and Biotechology Program
$5,639Hui-Kuan Lin · Wake Forest University Health Sciences · P30 · FY2019 · CA
25 Cancer Genetics and Epigenetics
$5,456Sharon R Dent · University Of Tx Md Anderson Can Ctr · P30 · FY2019 · CA
07 Gastrointestinal Cancers
$5,456Scott Kopetz · University Of Tx Md Anderson Can Ctr · P30 · FY2019 · CA
11 Prostate Cancer
$5,455Christopher J. Logothetis · University Of Tx Md Anderson Can Ctr · P30 · FY2019 · CA
Immunology and Cancer Immunotherapy (ICI)
$5,263Mary J Turk · Dartmouth College · P30 · FY2024 · CA